CSAM Health Group AS: Mandatory notification of trade

On 27 September 2023, CSAM Health Group AS changed its name to Omda AS. For articles on historical events such as transactions, financial results etc. we will not retroactively change the name.
Qevirp 47 Limited, a company controlled by Priveq Investment (“Priveq”), has today sold 870,000 shares in CSAM Health Group AS (“CSAM” or the “Company”), representing 4.2 per cent of the share capital in the Company, at a price per share of NOK 84.0 for total gross proceeds of approximately NOK 73 million. The shares were sold to two institutional investors in a process managed by Carnegie AS.


Following the share sale, Priveq owns 1,223,314 shares in CSAM, representing 5.9 per cent of the share capital in the Company. Priveq is represented on the Company’s Board of Directors by Louise Nilsson.
Einar Bonnevie
Chief Financial Officer

Related News

Omda delivers 11% growth in Q4
Read More
Invitation to presentation of Omda’s Q4 results
Read More
Omda ProSang 10 Is A Significant Next Step For Omda’s Blood Management Solution
Read More
Partial repurchase of OMDA01
Read More

Get in touch

Please enable JavaScript in your browser to complete this form.
Helen Døcker
Chief Marketing & Communications Officer
She is based in the company’s headquarters in Oslo, Norway.

Join our conversation to build a safer and healthier world.